脓毒症危重患者院内死亡预测:24小时乳酸对APACHE IV附加价值的验证
该研究旨在验证此前报道的24小时乳酸浓度单独及联合24小时乳酸清除率、入院乳酸浓度对脓毒症危重患者院内死亡预测的附加价值。推导队列来自荷兰Leiden的451例脓毒症危重患者,验证队列为2006年1月至2018年间波士顿Beth Israel Deaconness Medical Center ICU收治的4,440例脓毒症成人患者(MIMIC队列)。推导队列院内死亡160例(36%),验证队列2,347例(53%)。APACHE IV模型区分度中等(重校准C统计量0.62;95%CI 0.60-0.63),加入24小时乳酸浓度后重校准C统计量升至0.64(95%CI 0.62-0.66)。含24小时乳酸浓度和入院乳酸浓度的模型在推导与验证数据中赤池信息准则最小、拟合最佳。作者认为未来APACHE IV更新可考虑纳入基线和24小时乳酸浓度。
要点
- 验证队列4,440例脓毒症成人患者中院内死亡2,347例(53%),推导队列451例中死亡160例(36%)。
- APACHE IV模型区分度中等,重校准C统计量0.62(95%CI 0.60-0.63)。
- 加入24小时乳酸浓度后重校准C统计量升至0.64(95%CI 0.62-0.66)。
- 含24小时乳酸浓度与入院乳酸浓度的模型在推导和验证数据中赤池信息准则最小、拟合最佳。
- 24小时乳酸浓度和入院乳酸浓度对院内死亡预测的贡献为适度。
适用人群与场景
- 推导队列:荷兰Leiden的451例脓毒症危重患者。
- 验证队列:2006年1月至2018年间波士顿Beth Israel Deaconness Medical Center ICU收治的4,440例脓毒症成人患者(MIMIC队列)。
研究设计与关键结果
- 研究类型:预测模型验证研究;推导队列451例脓毒症危重患者,验证队列4,440例脓毒症成人患者(MIMIC队列)。
- 预测因子包括年龄、慢性合并症、ICU前住院时间、格拉斯哥昏迷评分和急性生理评分;将24小时乳酸浓度单独、联合24小时乳酸清除率、联合入院乳酸浓度分别加入模型评估预测改善,结局为院内死亡。
- 推导队列院内死亡160例(36%),验证队列院内死亡2,347例(53%)。
- APACHE IV模型区分度中等,重校准C统计量0.62(95%CI 0.60-0.63)。
- 加入24小时乳酸浓度后重校准C统计量升至0.64(95%CI 0.62-0.66)。
- 含24小时乳酸浓度和入院乳酸浓度的模型在推导和验证数据中赤池信息准则最小、拟合最佳。
证据类型、等级与局限
- 证据类型:预测模型验证研究(推导队列与验证队列)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,未来APACHE IV的更新和可能的修改应考虑纳入基线和24小时乳酸浓度。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: We previously reported the added value of 24-hour lactate concentration alone and in combination with 24-hour lactate clearance and lactate concentration at admission for the prediction of inhospital mortality in critically ill patients with sepsis. We aimed to validate this finding.
DERIVATION COHORT: The derivation cohort from Leiden, The Netherlands, consisted of 451 critically ill patients with sepsis.
VALIDATION COHORT: The validation cohort consisted of 4,440 critically ill adult patients with sepsis from the Medical Information Mart for Intensive Care cohort admitted to the ICU of Beth Israel Deaconness Medical Center, Boston, MA, between January 2006 and 2018.
PREDICTION MODEL: Predictors of mortality were: age, chronic comorbidities, length of stay pre-ICU, Glasgow Coma Scale, and Acute Physiology Score. Lactate concentration at 24-hour alone, in combination with 24-hour lactate clearance and in combination with lactate concentration at admission, was added to assess improvement of the prediction model. The outcome was inhospital mortality.
RESULTS: Inhospital mortality occurred in 160 patients (36%) in the derivation cohort and in 2,347 patients (53%) in the validation cohort. The Acute Physiology and Chronic Health Evaluation (APACHE) IV model had a moderate discriminative performance (recalibrated C-statistic, 0.62; 95% CI, 0.60-0.63). Addition of 24-hour lactate concentration increased the recalibrated C-statistic to 0.64 (95% CI, 0.62-0.66). The model with 24-hour lactate concentration and lactate concentration at admission showed the best fit as depicted by the smallest Akaike Information Criterion in both the derivation and validation data.
CONCLUSION: The 24-hour lactate concentration and lactate concentration at admission contribute modestly to prediction of inhospital mortality in critically ill patients with sepsis. Future updates and possible modification of APACHE IV should consider the incorporation of lactate concentration at baseline and at 24 hours.
参考来源
- Baysan M, Arbous MS, Steyerberg EW, et al. Prediction of Inhospital Mortality in Critically Ill Patients With Sepsis: Confirmation of the Added Value of 24-Hour Lactate to Acute Physiology and Chronic Health Evaluation IV. Crit Care Explor. 2022. PMID: 36082375. doi:10.1097/CCE.0000000000000750
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。